2 studies found for:    21612468 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: Alisertib;   Drug: Abiraterone acetate;   Drug: Prednisone
2 Completed
Has Results
Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Condition: Prostatic Neoplasms
Interventions: Drug: Placebo;   Drug: Abiraterone acetate;   Drug: Prednisone/prednisolone

Indicates status has not been verified in more than two years